DK1220676T3 - Forebyggelse af colorektal cancer - Google Patents

Forebyggelse af colorektal cancer

Info

Publication number
DK1220676T3
DK1220676T3 DK00962269T DK00962269T DK1220676T3 DK 1220676 T3 DK1220676 T3 DK 1220676T3 DK 00962269 T DK00962269 T DK 00962269T DK 00962269 T DK00962269 T DK 00962269T DK 1220676 T3 DK1220676 T3 DK 1220676T3
Authority
DK
Denmark
Prior art keywords
cancer
prostate
bladder
lung
prevention
Prior art date
Application number
DK00962269T
Other languages
Danish (da)
English (en)
Inventor
Hans Henrik Raskov
Original Assignee
Colotech As
Hans Henrik Raskov
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Colotech As, Hans Henrik Raskov filed Critical Colotech As
Application granted granted Critical
Publication of DK1220676T3 publication Critical patent/DK1220676T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
DK00962269T 1999-09-29 2000-09-29 Forebyggelse af colorektal cancer DK1220676T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA199901390 1999-09-29
PCT/DK2000/000546 WO2001022974A1 (en) 1999-09-29 2000-09-29 Prevention of colorectal cancer

Publications (1)

Publication Number Publication Date
DK1220676T3 true DK1220676T3 (da) 2005-09-05

Family

ID=8104340

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00962269T DK1220676T3 (da) 1999-09-29 2000-09-29 Forebyggelse af colorektal cancer

Country Status (13)

Country Link
US (1) US7851461B2 (de)
EP (1) EP1220676B1 (de)
AT (1) ATE294585T1 (de)
AU (1) AU779996B2 (de)
CA (1) CA2385755C (de)
DE (1) DE60019947T2 (de)
DK (1) DK1220676T3 (de)
ES (1) ES2240159T3 (de)
IS (1) IS2488B (de)
NO (1) NO330061B1 (de)
NZ (1) NZ517978A (de)
PT (1) PT1220676E (de)
WO (1) WO2001022974A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6538037B2 (en) 1991-01-08 2003-03-25 Bone Care International, Inc. Methods for preparation and use of 1α,24(S)-dihydroxyvitamin D2
US6566353B2 (en) 1996-12-30 2003-05-20 Bone Care International, Inc. Method of treating malignancy associated hypercalcemia using active vitamin D analogues
US6573256B2 (en) 1996-12-30 2003-06-03 Bone Care International, Inc. Method of inhibiting angiogenesis using active vitamin D analogues
US6503893B2 (en) 1996-12-30 2003-01-07 Bone Care International, Inc. Method of treating hyperproliferative diseases using active vitamin D analogues
ES2240159T3 (es) 1999-09-29 2005-10-16 Colotech A/S Prevencion del cancer colorrectal.
US20040071789A1 (en) * 2002-02-14 2004-04-15 Baron John A Calcium supplementation to reduce prostate cancer risk
DE60233869D1 (de) * 2001-04-05 2009-11-12 Colotech As Prävention von epithelzellkarzinom
US7094775B2 (en) 2004-06-30 2006-08-22 Bone Care International, Llc Method of treating breast cancer using a combination of vitamin D analogues and other agents
WO2011024208A1 (en) * 2009-08-24 2011-03-03 Colotech A/S Combination dosage form with acetylsalicylic acid, calcitriol and calcium
EP2695617B1 (de) * 2009-12-23 2019-01-09 Glycomyr Inc. Vitamin D Glycoside und Sulfate zur Behandlung von Darmerkrankungen
CA2865424A1 (en) 2011-02-28 2012-09-07 Rigshospitalet Copenhagen University Hospital Active vitamin d or analogs thereof for use in in vivo or in vitro fertilization

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0205025A1 (de) 1985-05-27 1986-12-17 Sumitomo Pharmaceuticals Company, Limited Fluorin enthaltende Vitamin-D3-Derivate und Zelldifferenzierung induzierende Mittel, die sie als aktiven Wirkstoff enthalten
KR0144358B1 (ko) 1988-04-21 1998-07-15 피. 라이달 크리스텐슨 비타민 d 동족체
EP0614455B1 (de) 1991-11-07 1996-02-21 Research Institute For Medicine And Chemistry Inc. Amid derivate von vitamin d
GB9206648D0 (en) 1992-03-26 1992-05-06 Leo Pharm Prod Ltd Chemical compounds
GB9226877D0 (en) 1992-12-23 1993-02-17 Leo Pharm Prod Ltd Chemical compounds
GB9309422D0 (en) 1993-05-07 1993-06-23 Res Inst Medicine Chem Chemical compounds
GB9314400D0 (en) 1993-07-12 1993-08-25 Leo Pharm Prod Ltd Produktionsaktieselskab) chemical compounds
GB9315253D0 (en) 1993-07-23 1993-09-08 Res Inst Medicine Chem Chemical compounds
DE4334154C2 (de) 1993-10-01 1997-05-22 Schering Ag 2-Halogeno-1,25-dihydroxy-cholecalciferole und pharmazeutische Zusammensetzungen
WO1996041645A1 (en) 1995-06-12 1996-12-27 G.D. Searle & Co. Combination of a cyclooxygenase-2 inhibitor and a leukotriene b4 receptor antagonist for the treatment of inflammations
US5948443A (en) 1996-02-23 1999-09-07 Medical Doctor's Research Institute, Inc. Acetylsalicylic acid and micronutrient supplementation for nutritional losses and coronary heart disease
US5770215A (en) * 1997-01-06 1998-06-23 Moshyedi; Emil Payman Multivitamin/vascular occlusion inhibiting composition
ES2240159T3 (es) 1999-09-29 2005-10-16 Colotech A/S Prevencion del cancer colorrectal.

Also Published As

Publication number Publication date
NO330061B1 (no) 2011-02-14
EP1220676B1 (de) 2005-05-04
CA2385755A1 (en) 2001-04-05
DE60019947D1 (de) 2005-06-09
US7851461B2 (en) 2010-12-14
ES2240159T3 (es) 2005-10-16
DE60019947T2 (de) 2006-02-02
PT1220676E (pt) 2005-08-31
AU7406300A (en) 2001-04-30
IS6317A (is) 2002-03-20
NO20021437D0 (no) 2002-03-22
ATE294585T1 (de) 2005-05-15
EP1220676A1 (de) 2002-07-10
CA2385755C (en) 2007-02-06
NO20021437L (no) 2002-05-24
AU779996B2 (en) 2005-02-24
NZ517978A (en) 2003-11-28
IS2488B (is) 2008-12-15
WO2001022974A1 (en) 2001-04-05
US20040116393A1 (en) 2004-06-17

Similar Documents

Publication Publication Date Title
BRPI0410503A (pt) uso da ivermectina para a fabricação de uma composição farmacêutica tópica, composição tópica e uso da composição
IL175158A0 (en) Tocopherol-modified therapeutic drug compounds
NO20062504L (no) Sammensetninger og doseringsformer for forbedret absorpsjon
BRPI0207961A8 (pt) Uso de análogos de epotilona e capecitabina para fabricar medicamento para tratar tumores cancerosos sólidos e kit compreendendo os referidos compostos.
BR0312573A (pt) Derivados de fenil-[4-(3-fenil-1h-pirazol-4-il)-pirimidin-2-il]-amina
CY1109661T1 (el) 5-cnac ως παραγοντας για χορηγηση απο το στομα τμηματων παραθορμονης
DK1259240T3 (da) Midler, såsom nikotinamid eller CADPR, til behandling af hudsygdomme
BRPI0508700A (pt) uso de sns-595, composição farmacêutica, e, pó liofilizado
AR109263A2 (es) Composición que comprende moxidectina
DK1220676T3 (da) Forebyggelse af colorektal cancer
UY26171A1 (es) Método y formulación farmacéutica para el tratamiento de la discinesia de aparición tardía
BRPI0415232A (pt) uso de xenÈnio com hipotermia para tratar asfixia neonatal
MXPA04001912A (es) Aminobenzofenonas novedosas.
TR200302134T4 (tr) 2-metil-tiazolidin-2,4-dikarboksilik asit ve/veya bunun fizyolojik olarak uygun tuzlarının anti-kanser ajanları olarak kullanımı.
DK1389122T3 (da) Forebyggelse af epitelcancer
EA200801890A1 (ru) Средство для лечения шума в ушах
MXPA05009849A (es) Terapia combinada que comprende nemorubicina y un inhibidor de la ciclooxigenasa-2.
BRPI0519006A2 (pt) uso de um inibidor de fbpase, kit de uma composiÇço farmacÊutica, uso de uma preparaÇço de biguanida e um inibidor de fbpase, agente terapÊutico para diabetes melito, e, combinaÇço de agentes terapÊuticos
SE0203817D0 (sv) New composition
WO2005105135A8 (en) Il-6 for therapy or prevention of chemotherapy-induced neuropathy
ATE346080T1 (de) Steroid-verbindungen mit anti-tumoraler wirkung
DK1490049T3 (da) Citalopram til behandling af forhöjet blodtryk
DK1962822T3 (da) Terapi af maligne neoplasier
DK1399143T3 (da) Anvendelsen af Acetyl L-carnitin til fremstilling af et lægemiddel til behandling af anhedoni
CL2004000633A1 (es) Compuestos copolimeros, composicion farmaceutica que los contiene y procedimiento de preparacion, utiles en el tratamiento de enfermedades metabolicas oseas.